Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,260 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Renin-angiotensin blocker use is associated with improved cardiovascular mortality in Indian patients with mild-moderate chronic kidney disease-findings from the ICKD study.
Prasad N, Yadav AK, Kundu M, Jaryal A, Sircar D, Modi G, Sahay M, Gopalakrishnan N, Vikrant S, Varughese S, Baid-Agrawal S, Singh S, Gang S, Parameswaran S, Ghosh A, Kumar V, Jha V. Prasad N, et al. Among authors: jha v. Front Med (Lausanne). 2022 Dec 20;9:1060148. doi: 10.3389/fmed.2022.1060148. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36606058 Free PMC article.
Indian TrANslational GlomerulonephrItis BioLogy nEtwork (I-TANGIBLE): Design and Methods.
Yadav K, Ramachandran R, Kumar V, Yadav AK, Pal D, Gopalakrishnan N, Sharma S, Priyamvada PS, Lahiri A, Sahay M, Raju SB, Sreelatha M, Manorajan R, Mukhopadhyay P, Prasad N, Meena P, Kohli HS, Vikrant S, Jha V. Yadav K, et al. Among authors: jha v. Indian J Nephrol. 2023 Jul-Aug;33(4):277-282. doi: 10.4103/ijn.ijn_305_23. Epub 2023 Aug 10. Indian J Nephrol. 2023. PMID: 37781560 Free PMC article.
Hydroxychloroquine plus personal protective equipment versus standard personal protective equipment alone for the prevention of COVID-19 infections among frontline healthcare workers: the HydrOxychloroquine Prophylaxis Evaluation(HOPE) trial: A structured summary of a study protocol for a randomized controlled trial.
Tirupakuzhi Vijayaraghavan BK, Jha V, Rajbhandari D, Myatra SN, John O, Ghosh A, Bassi A, Arfin S, Kunigari M, Joshi R, Donaldson L, Hammond N, Venkatesh B; HOPE investigators. Tirupakuzhi Vijayaraghavan BK, et al. Among authors: jha v. Trials. 2020 Aug 31;21(1):754. doi: 10.1186/s13063-020-04679-3. Trials. 2020. PMID: 32867852 Free PMC article.
Intent to share individual participant data of Indian clinical trials.
Borana R, Tyagi J, Di Tanna GL, Jha V, Bhaumik S. Borana R, et al. Among authors: jha v. Lancet Reg Health Southeast Asia. 2023 Nov 11;19:100318. doi: 10.1016/j.lansea.2023.100318. eCollection 2023 Dec. Lancet Reg Health Southeast Asia. 2023. PMID: 38025657 Free PMC article. No abstract available.
Trends in the Global Burden of Glomerulonephritis.
Bose B, Jha V. Bose B, et al. Among authors: jha v. Clin J Am Soc Nephrol. 2023 Jan 1;18(1):14-16. doi: 10.2215/CJN.0000000000000029. Clin J Am Soc Nephrol. 2023. PMID: 36719156 Free PMC article. No abstract available.
Hydroxychloroquine plus personal protective equipment versus personal protective equipment alone for the prevention of laboratory-confirmed COVID-19 infections among healthcare workers: a multicentre, parallel-group randomised controlled trial from India.
Tirupakuzhi Vijayaraghavan BK, Jha V, Rajbhandari D, Myatra SN, Ghosh A, Bhattacharya A, Arfin S, Bassi A, Donaldson LH, Hammond NE, John O, Joshi R, Kunigari M, Amrutha C, Husaini SHM, Ghosh S, Nag SK, Selvaraj HK, Kantroo V, Shah KD, Venkatesh B; HOPE Investigators. Tirupakuzhi Vijayaraghavan BK, et al. Among authors: jha v. BMJ Open. 2022 Jun 1;12(6):e059540. doi: 10.1136/bmjopen-2021-059540. BMJ Open. 2022. PMID: 35649613 Free PMC article. Clinical Trial.
Heterogeneity of treatment effect of higher dose dexamethasone by geographic region (Europe vs. India) in patients with COVID-19 and severe hypoxemia - a post hoc evaluation of the COVID STEROID 2 trial.
Tirupakuzhi Vijayaraghavan BK, Granholm A, Myatra SN, Jha V, Hammond N, Micallef S, Munch MW, Kjær MN, Møller MH, Lange T, Perner A, Venkatesh B; COVID-STEROID 2 collaborators. Tirupakuzhi Vijayaraghavan BK, et al. Among authors: jha v. Lancet Reg Health Southeast Asia. 2023 Oct 4;20:100293. doi: 10.1016/j.lansea.2023.100293. eCollection 2024 Jan. Lancet Reg Health Southeast Asia. 2023. PMID: 38234702 Free PMC article.
PROphylaxis for paTiEnts at risk of COVID-19 infecTion (PROTECT-V).
Humphrey TJL, Dosanjh D, Hiemstra TF, Richter A, Chen-Xu M, Qian W, Jha V, Gatley K, Adhikari R, Dowling F, Smith RM. Humphrey TJL, et al. Among authors: jha v. Trials. 2023 Mar 13;24(1):185. doi: 10.1186/s13063-023-07128-z. Trials. 2023. PMID: 36915199 Free PMC article.
1,260 results